Product NDC: | 68462-368 |
Proprietary Name: | Fosinopril Sodium |
Non Proprietary Name: | Fosinopril Sodium |
Active Ingredient(s): | 20 mg/1 & nbsp; Fosinopril Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68462-368 |
Labeler Name: | Glenmark Generics Inc., USA |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077222 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100621 |
Package NDC: | 68462-368-05 |
Package Description: | 500 TABLET in 1 BOTTLE (68462-368-05) |
NDC Code | 68462-368-05 |
Proprietary Name | Fosinopril Sodium |
Package Description | 500 TABLET in 1 BOTTLE (68462-368-05) |
Product NDC | 68462-368 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fosinopril Sodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100621 |
Marketing Category Name | ANDA |
Labeler Name | Glenmark Generics Inc., USA |
Substance Name | FOSINOPRIL SODIUM |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |